Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05425576
Title OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Oncotelic Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.